Science Explorer Back to mapMap
Discussion
Researcher · Brown Foundation · United States

Nami McCarty

Nami McCarty publishes mostly in Molecular Biology, Epidemiology and Pathology and Forensic Medicine, on topics such as Autophagy in Disease and Therapy, Lymphoma Diagnosis and Treatment and Ubiquitin and proteasome pathways.

ORCID 0000-0002-7384-5165 OpenAlex
World rank
#2,191,855
of 7,710,434 ranked researchers
Rank in United States
#657,931
of 1,627,098
Works
55
Citations
3.5k
Citations per work
63.8
h-index
17
i10-index 18Top 42% in Molecular Biology
Nami McCarty

What does Nami McCarty research?

Nami McCarty's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (30%), Immunology and Microbiology (9%).

Life Sciences: 25 works · 45.9% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 36.5% of their workMolecular Biology: 17 works · 31.3% of their workCell Biology: 3 works · 5.2% of their workImmunology and Microbiology: 5 works · 9.4% of their workImmunology: 5 works · 9.4% of their workHealth Sciences: 17 works · 30.2% of their workMedicine: 17 works · 30.2% of their workEpidemiology: 7 works · 12.5% of their workPathology and Forensic Medicine: 6 works · 10.4% of their workOncology: 4 works · 7.3% of their workEverything else: 13 works · 23.9% of their workTHEIR WORKNami McCarty55works
Life Sciences46%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2036.5%
    2. Immunology and Microbiology59.4%
    1. Medicine1730.2%
  3. Everything else1323.9%
  1. 1Molecular Biology31% of their works
  2. 2Epidemiology12% of their works
  3. 3Pathology and Forensic Medicine10% of their works
  4. 4Immunology9% of their works
  5. 5Oncology7% of their works
  6. 6Cell Biology5% of their works

Research topics

Which keywords describe Nami McCarty's research?

The keywords of their largest research topics: Apoptosis, Proteasome Inhibitors, Rituximab, Autophagy, Disease, Classification, Lymphoma and Proteasome.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Apoptosis172 topics
  2. Proteasome Inhibitors132 topics
  3. Rituximab132 topics
  4. Autophagy121 topic
  5. Disease121 topic
  6. Classification101 topic
  7. Lymphoma101 topic
  8. Proteasome81 topic
  9. Ubiquitin81 topic
  10. Diagnosis Criteria51 topic
  11. Endoplasmic Reticulum51 topic
  12. International Myeloma Working Group51 topic
  13. Stress51 topic
  14. Innate Immunity41 topic
  15. Viral Infection41 topic
  16. Chronic Lymphocytic Leukemia31 topic
  17. Genomic Aberrations31 topic
  18. NK Cell Recognition31 topic
  19. Natural Killer Cells31 topic

Where does Nami McCarty work?

Nami McCarty's main affiliation in the publication record is Brown Foundation, United States.

How many publications and citations does Nami McCarty have?

OpenAlex counts 55 works and 3,509 citations for Nami McCarty, an h-index of 17, ranking #2,191,855 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nami McCarty. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.